CPRX
Catalyst Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$31.49
+0.00%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -0.74x
- Debt / assets
- 0.00x
- Debt / EBITDA
- 0.01x
- Net debt / EBITDA
- -2.25x
Liquidity & coverage
- Current ratio
- 7.10x
- Quick ratio
- 6.84x
- Cash ratio
- 5.71x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $808.0M
Cash & dividend
- FCF / debt
- 77.63x
- Cash flow / debt
- 77.66x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026